Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
48,437,900
-
Share change
-
+2,056,800
-
Total reported value
-
$159,843,385
-
Put/Call ratio
-
60%
-
Price per share
-
$3.30
-
Number of holders
-
97
-
Value change
-
+$8,013,929
-
Number of buys
-
44
-
Number of sells
-
47
Institutional Holders of INOVIO PHARMACEUTICALS INC - COM NEW (INO) as of Q4 2019
As of 31 Dec 2019,
INOVIO PHARMACEUTICALS INC - COM NEW (INO) was held by
97 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,437,900 shares.
The largest 10 holders included
BlackRock Inc., WASATCH ADVISORS INC, VANGUARD GROUP INC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., ARK Investment Management LLC, STATE STREET CORP, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, and DIMENSIONAL FUND ADVISORS LP.
This page lists
97
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.